Contexium

ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV

ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV is a published development and funding opportunity on Contexium. The donor or funder is Department of Public Works and Government Services (PSPC). Project location(s): Canada. Applications close on 30 Sep 2026. Advanced Contract Award Notice(ACAN) - Vaccinia Immunoglobulin intravenous (human) (VIGIV) An ACAN is a public notice indicating to the supplier community that a department or agency intends to award a contract for goods, services or construction to a pre-identified supplier, thereby allowing other…

Opportunity overview

Project name
ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV
Department of Public Works and Government Services (PSPC) logo
Department of Public Works and Government Services (PSPC)
Donor
Department of Public Works and Government Services (PSPC)

Key details

Opportunity start date
Opportunity end date
Project location(s)
Canada

Summary

Advanced Contract Award Notice(ACAN) - Vaccinia Immunoglobulin intravenous (human) (VIGIV) An ACAN is a public notice indicating to the supplier...

Frequently asked questions

What is ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV?

ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV is a published development and funding opportunity on Contexium. The donor or funder is Department of Public Works and Government Services (PSPC). Project location(s): Canada. Applications close on 30 Sep 2026. Advanced Contract Award Notice(ACAN) - Vaccinia Immunoglobulin intravenous (human) (VIGIV) An ACAN is a public notice indicating to the supplier community that a department or agency intends to award a contract for goods, services or construction to a pre-identified supplier, thereby allowing other…

Who is funding ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV?

ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV is funded by Department of Public Works and Government Services (PSPC).

When is the deadline to apply for ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV?

The application deadline is 30 Sep 2026 18:00 (UTC).

Where will the ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV project take place?

The project location(s) are: Canada.

How can I apply for ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV?

Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.